Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Codexis, Inc. - Common Stock
(NQ:
CDXS
)
1.715
-0.015 (-0.87%)
Streaming Delayed Price
Updated: 11:11 AM EST, Dec 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Codexis, Inc. - Common Stock
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 07, 2025
Via
Benzinga
Codexis Inc (NASDAQ:CDXS) Plummets After Q3 2025 Revenue and Earnings Miss
↗
November 06, 2025
Codexis stock plunges after Q3 2025 earnings miss estimates, with revenue of $8.6M falling far short of expectations.
Via
Chartmill
Topics
Earnings
What's going on in today's after hours session
↗
November 06, 2025
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
A Look at Codexis's Upcoming Earnings Report
↗
August 12, 2025
Via
Benzinga
Preview: Codexis's Earnings
↗
May 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 14, 2025
Via
Benzinga
Codexis Revenue Jumps 91 Percent in Q2
↗
August 13, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 13, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Wednesday?
↗
August 13, 2025
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings)
↗
November 22, 2024
Via
Benzinga
Recap: Codexis Q4 Earnings
↗
February 28, 2024
Via
Benzinga
Codexis Inc (NASDAQ:CDXS) Surpasses Q2 2025 Earnings Expectations with Strong Revenue and EPS Beat
↗
August 13, 2025
Codexis Inc (CDXS) beat Q2 2025 revenue and EPS estimates, driving a 6.89% after-hours stock surge. Strong enzyme engineering and RNAi therapeutic progress fuel optimism.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 10, 2025
Via
Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
↗
May 28, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
Earnings Scheduled For August 13, 2025
↗
August 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 14, 2025
Via
Benzinga
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
October 22, 2024
From
Artiva Biotherapeutics, Inc.
Via
GlobeNewswire
CDXS Stock Earnings: Codexis Misses EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
CDXS stock results show that Codexis missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
CDXS Stock Earnings: Codexis Beats EPS, Beats Revenue for Q1 2024
↗
May 02, 2024
CDXS stock results show that Codexis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For May 14, 2025
↗
May 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
February 29, 2024
Via
Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
February 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
February 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
February 01, 2024
Via
Benzinga
Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough
↗
December 27, 2023
Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
